IP Library Granted Patent US 6,901,927
Granted Patent B2
US 6,901,927 · App. 10/303,240 · Granted Jun 7, 2005

Methods and devices for use in performing pulmonary procedures

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,901,927
App. No.
10/303,240
Granted
Jun 7, 2005
Kind
B2
Abstract

An implantable flow control element is provided which prevents air from entering an isolated portion of a patient's lung. The element may permit air to escape from the isolated portion so that the element acts like a valve. Systems for implanting pulmonary devices are also provided.

Claims (30)

1. A method of treating the lung, comprising the steps of:

advancing a device through an intrapulmonary path to a blocking element, the blocking element being previously implanted in a patient's lung for isolating a portion of a patient's lung;

performing a procedure with the device on the isolated portion of the patient's lung, the device extending through the previously implanted blocking element; and

removing the device after the performing step, wherein the blocking element prevents airflow in the inhalation direction after the device has been removed.

2. The method of claim 1 , wherein:

the advancing, performing and removing steps are carried out with the blocking element preventing air flow in an inspiratory direction but permitting air flow in an expiratory direction.

3. The method of claim 1 , wherein:

the performing step is carried out by applying suction through a lumen in the device.

4. The method of claim 3 , wherein:

the performing step is carried out to remove air from the isolated portion of the lung.

5. The method of claim 1 , wherein:

the performing step is carried out by delivering a therapeutic substance to the isolated portion of the lung through a lumen in the device.

6. The method of claim 5 , further comprising the step of:

removing material from the isolated portion of the lung after the performing step.

7. The method of claim 1 , further comprising the step of:

expanding an expandable member to occlude a pulmonary location.

8. The method of claim 1 , wherein:

the advancing step is carried out with the blocking element sealing around the device when the device is positioned therein.

9. A method of treating the lung, comprising the steps of:

advancing a device through a bronchial passageway to a blocking element, the blocking element being previously implanted in the bronchial passageway to control fluid flow to and from an isolated portion of a patient's lung;

performing a procedure with the device on the isolated portion of the patient's lung, the device extending through the previously implanted blocking element; and

removing the device after performing the procedure, wherein the blocking element prevents air flow through the bronchial passageway in the inhalation direction after the device has been removed.

10. The method of claim 9 , wherein:

the performing step is carried out by delivering a therapeutic substance to the isolated portion of the lung through a lumen in the device.

11. The method of claim 10 , further comprising the step of:

removing material from the isolated portion of the lung after the performing step.

12. The method of claim 9 , further comprising the step of:

expanding an expandable member to occlude a pulmonary location.

13. The method of claim 9 , wherein:

the advancing step is carried out with the blocking element sealing around the device when the device is positioned therein.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2009
From: EMPHASYS MEDICAL, INC.
To: PULMONX
Reel/Frame 023180/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2003
From: FOUNDRY, LLC., THE
To: EMPHASYS MEDICAL, INC.
Reel/Frame 014260/0945 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2003
From: DEEM, MARK E.; GIFFORD, HANSON S., III; FRENCH, RONALD; SUTTON, DOUGLAS
To: FOUNDRY, LLC., THE
Reel/Frame 014260/0952 →